Skip to main content

Warburg Pincus-backed Kalyan Jewellers revives IPO plans, may file for Rs 1,600-1,800 crore offer by August-end

The company has started work on the IPO and is likely to file its DRHP with Sebi by August-end or early September

 

Kalyan Jewellers, the leading Kerala-based jewellery retail firm backed by private equity giant Warburg Pincus, has revived plans to debut on Dalal Street by launching a Rs 1,800 crore initial public offering (IPO).

The company has started work on the IPO and is likely to file its DRHP (draft red herring prospectus) with market regulator Sebi by August-end or early September, people familiar with the matter told Moneycontrol. The decision comes on the back of a gradual recovery in demand in the domestic jewellery sector after the pounding from the COVID-19 outbreak.

The IPO hiatus in the markets due to the coronavirus lockdown ended on July 23 when speciality chemicals firm Rossary Biotech made a blockbuster stock market debut.

“Kalyan Jewellers is looking to raise around Rs 1,600-Rs 1,800 crore through a mix of primary and secondary issue of shares. Their numbers as of March are healthy. With the organised jewellery sector slowly heading towards normalcy, this has given confidence to the firm,” one of the persons cited above told Moneycontrol. The firm had evaluated an IPO in early 2018 but deferred those plans.


“Axis Capital, Citi, ICICI Securities and SBI Capital are the investment banks working on the IPO for Kalyan Jewellers. The listing will provide a partial exit to Warburg Pincus and will also facilitate debt reduction,” a second person said.

A third person said January to March 2021 would be an ideal window to launch the Kalyan Jewellers IPO after securing the requisite approvals. "If the plans fructify and are successful, it could enthuse peers like Joyallukas and Malabar Jewellers to evaluate the listing route.”

All the three individuals spoke to Moneycontrol on the condition of anonymity. Moneycontrol has sent reminders and is awaiting an email response from Kalyan Jewellers. Warburg Pincus and Citi declined to comment and Moneycontrol is awaiting replies from Axis Capital, ICICI Securities and SBI Capital.

Kalyan Jewellers: Prospects shinier now?

Warburg Pincus has collectively invested around Rs 1,700 crore in two tranches in Kalyan Jewellers in lieu of an undisclosed minority stake. Its initial investment of Rs 1,200 crore in 2014 was the biggest private equity investment ever in the jewellery sector in India, followed by a second smaller round of Rs 500 crore in 2017.

According to a report released by rating agency ICRA in September 2019, Warburg Pincus has a 30 percent stake in the jewellery firm. Kalyan Jewellers had an operating income of Rs 7,454 crore and a profit after tax (PAT) of Rs 50 crore in FY19, the report said.

Kalyan Jewellers has over 135 showrooms across 19 states and two Union Territories and also has an online brand called ‘Candere by Kalyan Jewellers’. The firm is present in five countries, including the Middle East region, and has over 750 ‘My Kalyan’ stores in India, which function as customer touch points and feeders to the showrooms.

Gold prices have hit record highs in recent weeks due to a spike in demand for safe assests on the back of a weaker dollar and rising COVID-19 cases.

The top five stocks in the gems and jewellery sector, based on market capitalisation (with the exception of Rajesh Exports), have surged sharply since the beginning of the nationwide lockdown.

This signals a slow restoration to pre COVID-19 levels in terms of demand, footfalls and sales. The likes of Vaibhav Global, PC Jewellers, Renaissance Global and Titan have seen their stock prices rising by 105 percent, 84 percent, 40 percent and 27 percent, respectively.

Recently, due to the COVID-19 pandemic, the government extended the deadline for mandatory hallmarking of gold jewellery and artefacts by four months till June 1, 2021. Hallmarking is a purity certification and will introduce standardisation in the market. Jewellers have been given time by the government to shift to hallmarking and register themselves with the Bureau of Indian Standards.


Source - Moneycontrol.com
Labels:

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...
Post a Comment
Read more